☀ Trending Among Corona Carnage ☀ List of Best Performing Corona Vaccine Stocks, Healthcare Stocks, and Artificial Intelligence Stocks. A year ago, it was diffcult to believe what an invisible virus can do to the global economy. Jobs are lost, businesses have been shut, transportation has been stopped, and above all - lives have been wrecked to enormous magnitude. As the world eagerly awaits for the most accurate vaccine with negligible side-effects, there are efforts on for a finding a treatment for Covid. Many major companies are working round the clock to find a cure to the corona virus disease, to prepare the most accurate vaccine, or to ramp up the production of already available corona vaccines. Investors can take a shot at such company shares by investing in them. This article provides a list of Covid-related stocks which have generated the highest returns in the year 2021 till date of writing. The list is prepared based on the percentage returns generated by the individual Covid stocks between the end of the previous and May 4, 2021, and the top 10 return generating Covid stocks are listed below. Additionally, one can also explore the best performing stocks of other new-age investment themes like the Best Performing Healthcare Stocks, Best Performing Biotech Stocks, and Best Performing Major Pharmaceuticals Stocks.
Try our new Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Covid sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) Biontech SE (BNTX)
Here's a look at the basic details and how the above mentioned stocks fared during the period:
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 for prostate cancer; BNT113 that is in Phase I clinical trial to treat HPV+ head and neck cancers; BNT114, which is in Phase I clinical trial for ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Biontech SE. Biontech SE (BNTX) generated percentage returns of 116.98 percent during the 2021 year-to-date. Its returns are based on the share price which moved from $81.52 per share from the previous year-end to the price of $176.88 per share as of May 4, 2021. The company's value, as indicated by the market-cap figure, changed from $19.63 billion to $42.72 billion during the same period. The company is categorized as a Healthcare speciality business with further classification in the Biotechnology sub-category. Based in Mainz, Germany, the YTD performance of the Covid sector also fared better than that of the returns generated by some of the closley tracked stock market indexes.
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus, and VIR-2020 for the prevention of tuberculosis. The company ha ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Vir Biotechnology. Vir Biotechnology, Inc. (VIR) has moved by 66.43 percentage over the given period of 2021-YTD, helping it gain a place at number two among the top performing stocks. The Healthcare sector company managed to achieve the feat as its stock price changed from $26.78 apiece to the price of $44.57 per share between the end of December of the previous year and May 4, 2021. The smart run of the San Francisco, CA-based Biotechnology sector company lead to a handsome gain in its marketcap which changed from $3.41 billion to $5.78 billion over the same duration. Vir Biotechnology is a key member of many popular stock market indexes. They include Russell 2000 index, and several other broader level multi-cap market indicators.
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic va ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Moderna. During the given months of the year 2021, Moderna, Inc. (MRNA) was successful in generating YTD returns of 66.16 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2021 till date. As of December of the previous year, the stock of the Cambridge, MA-based Moderna closed at a price of $104.47 per share, while it traded at a price of $173.59 per share as of May 4, 2021. The company's market cap changed from $41.34 billion to $69.53 billion during the same period YTD. It ranks as a key constituent of major indexes that include NASDAQ 100 index, and several other broader level multi-cap market indicators.
The company is classified under the Healthcare industry sector and further specialized as a Healthcare sector business.
Novavax, Inc. (Novavax), incorporated on June 18, 1987, is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Novavax. Rank number four in the coveted list is held by Novavax, Inc. (NVAX) for being among the top performing stocks of 2021. Headquartered in Maryland, MD, the Healthcare sector company is categorized under the industrial sub-sector of Biotech Biological Products. Since the start of the year 2021, stock of Novavax has so far gained 62.02 percentage, based on the previous year's closing price of $111.51 per share and year-to-date price of $180.67 per share. During the same period, the market capitalization of the company changed from $7.1 billion to $13.39 billion. The stock of Novavax continues to be a major constituent of many leading stock indexes which include Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators.
Gilead Sciences, Inc., incorporated on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Companys portfolio of products ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Gilead Sciences. At number five in the list of top stocks stands Gilead Sciences (GILD), which saw a change in its stock price from the level of $58.26 apiece during previous year December end to the price of $65.64 per share as of May 4, 2021. It translates to a change of 12.67 percentage. The Foster City, California-headquartered Healthcare sector company also saw its market value change from $73.03 billion to $82.65 billion. The Biotech Biological Products specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the NASDAQ 100 index, Wilshire 5000 index, S&P 500 index, and a handful of other multi-capitalization indexes.
Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Pfizer. The New York, NY-based Pfizer, Inc. (PFE) belongs to the Healthcare sector and is categorized as a Major Pharmaceuticals company. The stock of Pfizer ended the previous year at a price of $36.81 per share. As of May 4, 2021, the stock price has reached $39.95 apiece, which indicates a change of 8.53 percent making the company rank among the top performing stocks of the Covid for the year 2021 till date. At the end of the last year, company's market capitalization stood at $204.61 billion. It has now changed to $222.85 billion as of writing. Pfizer continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, S&P 500 index, and several other broader level multi-cap market indicators.
Johnson and Johnson
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharma ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Johnson and Johnson. The New Brunswick, New Jersey-based Healthcare sector company Johnson and Johnson (JNJ) holds the number seven spot among the best performing stocks of the Covid sector. Classified as the Major Pharmaceuticals business, the stock price of Johnson and Johnson ended the previous year at a price of $157.38 per share while it reached the level of $167.77 apiece as of May 4, 2021 translating to a percentage change in stock price of 6.6%. As of writing, the company's market-cap value stands at $441.81 billion. Few leading stock market index includes Johnson and Johnson in their constituent list. They include Wilshire 5000 index, Dow Jones Industrial Average index, S&P 500 index, and a few other larger indexes which are part of the stock market.
AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of AbbVie. The North Chicago, Illinois-headquartered company AbbVie Inc. (ABBV) is ranked number eight among the best performing stocks of Covid of 2021. The Healthcare sector business falls under the Major Pharmaceuticals industrial sub-sector. Since the start of the year 2021, the stock price of AbbVie has changed by 6.3 percent, which is calculated based on the previous year's closing price of $107.15 per share and year-to-date closing price of $113.9 per share as of writing. The market value of the company as indicated by its market-cap changed from $189.17 billion to $201.01 billion during the same period. Along with Covid, the company is also in the business of Health Care, Major Pharmaceuticals, Major Drug Manufacturers, Pharma, Healthcare, Dividend Aristocrats, S&P 500, Cannabis, Marijuana, Wilshire 5000, ESG, among other usual products and services. AbbVie continues to be a leading constituent of many major stock market indexes like S&P 500 index, Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Sanofi, incorporated on May 11, 1994, is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Companys segments are ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Sanofi. The number nine spot in the list of top performing stocks of the Covid sector is taken by Sanofi (SNY). The company's stock price changed from $48.59 per share at the end of December of the previous year to the price of $50.42 per share as of writing. Overall, the stock managed to realized price change of 3.77 percent during the given time period. The corresponding change in the market capitalization value of the France-based Healthcare sector company was from $121.97 billion to $130.77 billion. Being ranked in the top 10 best performing stocks of the Covid sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes.
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of GlaxoSmithKline. Based on the market-cap change from $91.38 billion to $92.71 billion during the given months of the year 2021 and the share price change from $36.8 per share to a price of $37.5 per share as of May 4, 2021, GlaxoSmithKline PLC (GSK) was successful in generating YTD returns of 1.9 percentage. Standing at the number ten rank in the top performing list of Covid stocks, the Brentford, -based GlaxoSmithKline is categorized as the Major Pharmaceuticals sub-sector business which falls under the larger Healthcare sector.This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.